<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01415284</url>
  </required_header>
  <id_info>
    <org_study_id>LoubertHMR2011/01</org_study_id>
    <nct_id>NCT01415284</nct_id>
  </id_info>
  <brief_title>ED50 Determination of Hydroxyethylstarch for Treatment of Hypotension During Cesarean Section Under Spinal Anesthesia</brief_title>
  <official_title>ED50 Determination of Hydroxyethylstarch for Treatment of Hypotension During Cesarean Section Under Spinal Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maisonneuve-Rosemont Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Université de Montréal</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Maisonneuve-Rosemont Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this trial is to determine the effective volume of hydroxyethylstarch 130/0.4
      which would prevent the occurence of maternal hypotension in 50% of healthy pregnant women
      undergoing a cesarean section under spinal anesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The incidence of spinal anesthesia-induced hypotension in pregnant women undergoing a
      cesarean section is high. A preoperative fluid bolus of undetermined volume is frequently
      administered to lower the incidence of maternal hypotension, with a somewhat poor efficacy.
      Recently, several investigations have shown that the use of a phenylephrine infusion after
      the induction of spinal anesthesia results in a significant reduction in hypotensive
      episodes. Given the high efficacy of this therapy (incidence of hypotension around 20%), it
      is possible to determine the effective volume of fluid which would prevent hypotension in 50%
      of the patients studied (ED50).

      Healthy term pregnant women undergoing elective cesarean section under spinal anesthesia will
      be recruited in this trial. The spinal anesthesia regimen will be standardized and all
      subjects will receive a phenylephrine infusion. The fluid investigated is hydroxyethylstarch
      (HES) 130/0.4 (Volulyte(R)). The ED50 will be determined using an up-down sequential
      allocation method initially described by Dixon &amp; Massey. The determination of the HES ED50
      will help the anesthesiologist in further treating maternal hypotension appropriately.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2011</start_date>
  <completion_date type="Anticipated">June 2013</completion_date>
  <primary_completion_date type="Anticipated">June 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Volume of HES which will prevent hypotension if 50 % of the subjects.</measure>
    <time_frame>4 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of hypotension episodes</measure>
    <time_frame>1 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of hypertensive episodes</measure>
    <time_frame>1 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cardiac output</measure>
    <time_frame>1 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apgar score</measure>
    <time_frame>10 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>umbilical artery pH</measure>
    <time_frame>2 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>additional vasopressors administered</measure>
    <time_frame>1 hour</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Obstetric Anesthesia</condition>
  <condition>Spinal Anesthesia</condition>
  <condition>Hypotension</condition>
  <condition>Fluid Therapy</condition>
  <condition>Cesarean Section</condition>
  <arm_group>
    <arm_group_label>Hydroxyethylstarch 130/0.4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydroxyethylstarch 130/0.4</intervention_name>
    <description>first patient : 500 mL. Following volumes according to up-down sequential allocation, with increments or decrements of 100 mL. An absence of hypotension will lead to an decrement while a presence of hypotension will result in an increment.</description>
    <arm_group_label>Hydroxyethylstarch 130/0.4</arm_group_label>
    <other_name>Voluven</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy pregnant women (ASA I or II)

          -  Normal pregnancy

          -  Term gestation (37 weeks and above)

          -  Elective cesarean section

          -  Spinal anesthesia

        Exclusion Criteria:

          -  Cardiopathies

          -  Hypertensive disease/ pre-eclampsia / eclampsia

          -  Any contraindication to neuraxial anesthesia

          -  Patient refusal

          -  Body mass index &gt; 30 at first antenatal visit and &gt; 32 at cesarean section

          -  Twin pregnancy

          -  Known allergies to HES

          -  Emergency cesarean section
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Loubert, MD, FRCPC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maisonneuve-Rosemont Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christian Loubert, MD, FRCPC</last_name>
    <phone>514.252.3426</phone>
    <email>loubertch@yahoo.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Louis-Philippe Fortier, MD, FRCPC</last_name>
    <phone>514.252.3426</phone>
    <email>lpfortier@mac.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Maisonneuve-Rosemont Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H1T 2M4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Loubert, MD, FRCPC</last_name>
      <phone>514.252.3426</phone>
      <email>loubertch@yahoo.fr</email>
    </contact>
    <contact_backup>
      <last_name>Louis-Philippe Fortier, MD, FRCPC</last_name>
      <phone>514.252.3426</phone>
      <email>lpfortier@mac.com</email>
    </contact_backup>
    <investigator>
      <last_name>Christian Loubert, MD, FRCPC</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre-Olivier Gagnon, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Louis-Philippe Fortier, MD, FRCPC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre Drolet, MD,FRCPC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 10, 2011</study_first_submitted>
  <study_first_submitted_qc>August 10, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2011</study_first_posted>
  <last_update_submitted>February 12, 2013</last_update_submitted>
  <last_update_submitted_qc>February 12, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 15, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Maisonneuve-Rosemont Hospital</investigator_affiliation>
    <investigator_full_name>Christian Loubert</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>Obstetric anesthesia</keyword>
  <keyword>Spinal anesthesia</keyword>
  <keyword>Hypotension</keyword>
  <keyword>Fluid therapy</keyword>
  <keyword>Cesarean section</keyword>
  <keyword>phenylephrine</keyword>
  <keyword>cardiac output</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Hydroxyethyl Starch Derivatives</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

